Terrence Park

Terrence Park has a diverse work experience in the biotechnology and pharmaceutical industry. Terrence started their career at Exelixis as a Research Associate in 2005. In 2004, they worked at AGY Therapeutics as a Research Associate II. From 2006 to 2019, Terrence Park worked at Pfizer in various roles. In the CNS Group from 2006 to 2010, they focused on in-vitro screening for preclinical targets related to Alzheimer's disease. From 2010 to 2015, they worked in the Metabolism Group, conducting in-vivo and in-vitro screening of preclinical diabetes targets. And from 2015 to 2019, they were part of the IO Group, serving as the in-vivo biology lead for multiple immune-oncology targets. In October 2019, Terrence Park joined Asher Biotherapeutics as a Sr. Scientist, specializing in in-vivo biology.

Terrence Park attended the University of California, Davis from 1995 to 2000, where they obtained a Bachelor of Science degree in Neurobiology, Physiology, and Behavior. Following this, from 2001 to 2003, they pursued another Bachelor of Science degree in Computer Science at California State University - East Bay.